Infectious Disease Testing Market Remains Dynamic Amid Post-Pandemic Shifts and New Innovations
ARLINGTON, Va., June 19, 2025 /PRNewswire/ — Kalorama Information, a trusted source for healthcare market intelligence, released insights into the evolving global market for infectious disease testing through the In Vitro Diagnostics Business Outlook newsletter. Despite the decline in COVID-19 testing, the overall infectious disease diagnostics market remains robust, supported by sustained demand for non-COVID tests and the adoption of next-generation technologies across both laboratory and point-of-care (POC) settings.
With testing essential for diagnosing, monitoring, and containing a wide range of infections—from respiratory illnesses and bloodborne viruses to sepsis and gastrointestinal pathogens—the market continues to attract significant attention and investment. Kalorama's latest report highlights a steady shift in growth drivers, with POC solutions, molecular platforms, and advanced immunoassays gaining ground.
'Infectious disease diagnostics continues to be one of the most innovative segments of the IVD industry,' said Daniel Granderson, Senior Editor of Kalorama Information. 'New technologies are not only enhancing diagnostic speed and accuracy but are also reshaping where and how testing is performed—bringing more solutions to decentralized and resource-limited settings.'
Highlights from the article include:
Strong global demand for lab-based immunoassays and molecular tests Continued innovation in syndromic panels, microfluidics, and cartridge-based POC platforms A growing share of the market shifting toward emerging regions, with Asia Pacific and other developing areas seeing increased diagnostic infrastructure and demand Major industry players—including Roche, Abbott, Danaher, and QIAGEN—introducing new products to address unmet needs in STIs, sepsis, and respiratory diseases
The report also profiles emerging innovators bringing AI-powered diagnostics, rapid sepsis panels, and cost-effective molecular tools to market, emphasizing the industry's ongoing focus on speed, accuracy, and accessibility.
For more insights on market forecasts, regional dynamics, and comprehensive market views, visit Kalorama Information's IVD Business Outlook.
About IVD Business Outlook
In Vitro Diagnostics Business Outlook is a bimonthly publication from Kalorama Information, offering six issues annually—each dedicated to a distinct segment of the IVD industry. Designed for decision-makers across diagnostics and life sciences, the publication delivers exclusive market intelligence, including growth forecasts, market sizing, and share analysis. Each issue features in-depth coverage of diagnostic test categories, company profiles, mergers and acquisitions, regional trends, and expert analysis of key industry developments. With curated insights not found in mainstream sources, In Vitro Diagnostics Business Outlook is an essential resource for staying ahead in the global diagnostics market.
About Kalorama InformationKalorama Information, a division of Science and Medicine Group, is a leading provider of healthcare market research, delivering actionable intelligence to diagnostics, biotechnology, medical device, and pharmaceutical companies worldwide.
Website: https://www.kaloramainformation.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malaysian Reserve
an hour ago
- Malaysian Reserve
Johnson Pope Expands Legal Talent with the Addition of Jessica Warwick and Samuel C. Craig to Its St. Petersburg Office
ST. PETERSBURG, Fla., June 20, 2025 /PRNewswire/ — Johnson, Pope, Bokor, Ruppel & Burns, LLP is proud to announce the addition of two new associate attorneys, Jessica Warwick and Samuel C. Craig, to its St. Petersburg office. These strategic hires reflect the firm's continued growth and commitment to serving clients with deep, specialized knowledge across key practice areas. Jessica Warwick Joins Healthcare Practice GroupJessica Warwick has joined Johnson Pope's Healthcare Practice Group, where she advises hospitals, health systems, and medical providers on a wide range of regulatory and compliance matters. Her areas of focus include telemedicine, the corporate practice of medicine, and Medicare/Medicaid compliance. Jessica holds both a Juris Doctor and a Master of Health Administration from Penn State. Her experience includes drafting and negotiating management and professional services agreements, conducting regulatory compliance reviews for digital health platforms, and supporting healthcare M&A transactions. Jessica is admitted to the Florida Bar and currently serves as the Health and Wellness Chair for the Pinellas County chapter of the Florida Association for Women Lawyers. Samuel C. Craig Joins Tax, Trusts & Estates Practice GroupsSamuel C. Craig has joined Johnson Pope as an associate in the Tax, Trusts & Estates and Business Transactions Practice Groups. Sam focuses his practice on estate planning, tax law, and business matters, providing practical, strategic counsel to individuals, families, and business owners. Sam earned his J.D. from Stetson University College of Law, where he was a research assistant, president of the Business Law Society, and a member of both the Dispute Resolution Board and Trial Team. He received multiple awards for oral advocacy, including a national mock trial championship and induction into the National Order of the Barristers. He later earned his LL.M. in Taxation from the University of Florida on a merit scholarship where he earned multiple CALI book awards, further honing his knowledge of federal and state tax law. Sam is dedicated to helping clients protect their legacies, minimize tax burdens, and navigate complex legal issues with clarity and care. About Johnson PopeJohnson, Pope, Bokor, Ruppel & Burns, LLP is a full-service Florida-based law firm with offices in Tampa, Clearwater, and St. Petersburg. The firm is known for its commitment to excellence, innovative legal solutions, and deep roots in the communities it serves. To learn more, visit
Malaysian Reserve
an hour ago
- Malaysian Reserve
Molecular Point-of-Care (mPOC) Market Reaches $1.8 Billion: Kalorama Report Spotlights Rapid PCR Innovation and Expanding Frontiers in STI and HAI Testing
ARLINGTON, Va., June 20, 2025 /PRNewswire/ — Kalorama Information, a leading authority in in vitro diagnostics (IVD) market research, has released Molecular Point-of-Care (mPOC) Market Outlook and Innovations, 2024–2029, estimating the global mPOC market at $1.8 billion in 2024. The report offers a comprehensive forecast through 2029, highlighting transformative opportunities in respiratory, sexually transmitted, and hospital-acquired infection diagnostics at or near the point of care. 'While the molecular point-of-care market saw unprecedented acceleration during the COVID-19 pandemic, Kalorama's latest analysis reveals it now stands on a firmer foundation with renewed growth expected,' said Justin Saeks, senior market analyst and report author. 'We anticipate an almost double-digit compound annual growth rate for the 'true' mPOC segment as demand spreads beyond COVID to broader respiratory panels, STIs, HAIs, and tropical diseases.' Key Findings from the Report: Respiratory testing dominates the market, with COVID-19, flu, strep, and RSV continuing to drive system adoption, particularly for combination tests. Growth expected in HAIs and STIs, although these will evolve more slowly due to testing infrastructure and workflow differences across care settings. 'True' mPOC segment revenues, which had recently declined, are projected to achieve a substantial CAGR from 2024 to 2029. Kalorama differentiates between 'true' mPOC platforms and near-patient systems, offering detailed segmentation by company, region, and disease target. Abbott and Cepheid lead their respective segments. True mPOC Systems: Compact, fast, CLIA-waived (or with waiver potential), and operable by non-lab personnel. Key players include Abbott (market leader), Roche, Cepheid, QuidelOrtho, BioFire, and Sekisui. Near-Patient Molecular Systems: Encompasses larger non-POC systems and smaller platforms with POC or near-POC potential. BioFire and Cepheid are major competitors, with Cepheid leading this segment. Why It Matters Now The report's release is timely as healthcare providers seek diagnostic solutions that balance speed, accuracy, and accessibility across both developed and resource-limited settings. mPOC systems bring the power of molecular testing to emergency departments, outpatient clinics, nursing homes, mobile labs, and even homes—enabling timely treatment decisions and improving care outcomes. 'POC molecular diagnostics represent one of the most important intersections between innovation and access in global health,' said Alisa Alvich, Marketing Director at Science and Medicine Group, Kalorama Information's parent company. 'Kalorama's analysis shows where this market is headed and what players must consider to stay competitive.' Audience Impact This research is essential for: Product Managers and R&D leaders developing decentralized molecular platforms. Corporate strategy teams evaluating new market opportunities or CLIA-waived innovations. Investors and M&A professionals scouting high-growth segments or acquisition targets. Clinical lab and procurement teams optimizing test menus for decentralized care delivery. With deep dives into market sizing, disease applications, regional dynamics, and competitive intelligence, Molecular Point-of-Care (mPOC) Market Outlook and Innovations, 2024–2029 equips life sciences professionals with the insights needed to navigate a rapidly evolving diagnostics frontier. Get the Report Molecular Point-of-Care (mPOC) Market Outlook and Innovations, 2024–2029 is now available for purchase at: For purchasing inquiries or to schedule a custom consultation, contact:Sheri Davie – Sales Director, Kalorama About Kalorama Information Kalorama Information, part of Science and Medicine Group Inc., is a trusted publisher of market research exclusively focused on the healthcare industry. For over 25 years, Kalorama has delivered accurate, timely, and strategic intelligence to leaders in biotechnology, clinical diagnostics, in vitro diagnostics (IVD), pharmaceuticals, medical devices, and broader healthcare sectors. Originally launched in 1998, Kalorama Information quickly established itself as a premier source of insight into U.S. and global medical markets. Today, Kalorama remains a leading authority on healthcare market dynamics, with a particular emphasis on IVD. Kalorama is best known for its flagship title, The Worldwide Market for In Vitro Diagnostic Tests, an internationally recognized benchmark in the diagnostics field. Other reports published throughout the year cover these and other healthcare topics in greater detail. Our innovative approach to research, combined with deep industry expertise, has made Kalorama a go-to resource for top healthcare companies, strategic planners, investors, and media seeking authoritative market data and trends. With a singular focus on healthcare, Kalorama continues to shape informed decision-making across the industry through comprehensive, evidence-based analysis. Kalorama also works in coordination with other Science and Medicine Group brands, including BioInformatics, which focuses on life science markets and marketing, SDi, the leading source of information on the laboratory life science and analytical instrumentation industry and publisher of IBO, its twice-monthly newsletter, and IMV, which publishes reports and data on the medical imaging and clinical markets. For more information about Kalorama Information and other services offered by Science and Medicine Group, please visit our website.
Malaysian Reserve
2 hours ago
- Malaysian Reserve
Outdated Inventory Systems Are Costing Retailers: Info-Tech Research Group Publishes Insights on How AI Can Make a Difference
Global research and advisory firm Info-Tech Research Group has published new research insights to help retailers leverage AI effectively amidst evolving supply chain and inventory management challenges. The firm's resource walks retail industry IT leaders through seven steps to develop AI strategies that optimize stock levels, streamline operations, and respond faster to market changes. TORONTO, June 20, 2025 /PRNewswire/ – Inventory has become one of retail's most expensive guessing games. As customer expectations evolve faster than supply chains can respond, retailers are often stuck choosing between empty shelves and excess stock, both of which erode margins. In response to these growing industry challenges for organizations and their IT teams, Info-Tech Research Group has published Build Your AI Strategy for Retail Inventory Management, a practical blueprint that helps retailers transition from outdated inventory methods to intelligent, data-driven operations. The global research and advisory firm's new resource outlines how industry IT leaders can apply AI to improve forecasting, optimize stock levels, and deliver measurable performance gains. Adoption Challenges Are Slowing AI Integration in Retail Inventory Systems Info-Tech reports in its recently published resource that despite the clear benefits of AI in transforming retail inventory management, many organizations face significant challenges in adoption. The firm's research insights highlight that aligning the business stakeholders to develop a cohesive AI strategy remains a common hurdle, especially when it involves addressing existing inventory limitations and identifying critical gaps. Additionally, realizing AI's full potential often requires mature data infrastructure and advanced system capabilities that not all retailers have in place. 'Inventory management applications that are AI-driven can deliver where traditional inventory management falls short,' says Donnafay MacDonald, research director at Info-Tech Research Group. 'By providing real-time insights backed by big data, these applications enable retailers to respond to market changes through predictive forecasts that reduce waste, improve operational efficiency, and enhance customer satisfaction.' Info-Tech Recommends a Seven-Step AI Implementation Framework for Retail IT Leaders To support IT and business leaders in overcoming these barriers, Info-Tech offers a clear, step-by-step framework featuring a practical use-case library. The blueprint outlines seven key steps to guide retail IT leaders in developing and executing an AI strategy tailored to their inventory needs. These include: Formulating an AI strategy aligned to business goals. Define how AI will drive key objectives such as boosting customer satisfaction, cutting costs, or increasing agility and set clear success metrics. Establishing responsible AI principles. Put ethical, privacy, and governance guardrails in place to ensure transparent, fair, and secure AI solutions. Launching targeted AI initiatives. Start with pilots such as demand forecasting or automated replenishment to prove value and build momentum. Building a use case library. Catalog specific applications such as dynamic pricing or shelf space optimization with defined benefits, data needs, and technical requirements. Evaluating value and feasibility. Estimate ROI, resource demands, and risks for each use case to spotlight quick wins and flag longer term projects. Prioritizing projects. Rank initiatives by impact, effort, and risk so teams invest where they will see the fastest, biggest returns. Mapping out an AI roadmap. Sequence pilots and rollouts with clear milestones for data readiness, model validation, and performance reviews. InfoTech advises that by addressing longstanding challenges in inventory management, retailers have an opportunity to adopt smarter, more resilient systems that reflect the realities of today's retail environment. With competitors already incorporating AI into their everyday operations, the pressure to evolve is intensifying for IT leaders. The firm's blueprint provides retailers with straightforward, actionable guidance to implement AI in a way that supports business goals without adding unnecessary complexity. Info-Tech explains that with the right tools and direction, retailers can improve product availability, streamline operations, and respond to demand shifts with greater confidence and control. For exclusive and timely commentary from Donnafay MacDonald, an expert in the retail sector, and access to the complete Build Your AI Strategy for Retail Inventory Management blueprint, please contact pr@ About Info-Tech Research GroupInfo-Tech Research Group is one of the world's leading research and advisory firms, serving over 30,000 IT and HR professionals. The company produces unbiased, highly relevant research and provides advisory services to help leaders make strategic, timely, and well-informed decisions. For nearly 30 years, Info-Tech has partnered closely with teams to provide them with everything they need, from actionable tools to analyst guidance, ensuring they deliver measurable results for their organizations. To learn more about Info-Tech's divisions, visit McLean & Company for HR research and advisory services and SoftwareReviews for software buying insights. Media professionals can register for unrestricted access to research across IT, HR, and software and hundreds of industry analysts through the firm's Media Insiders program. To gain access, contact pr@ For information about Info-Tech Research Group or to access the latest research, visit and connect via LinkedIn and X.
